MEDICA 2026 | 16–19 November 2026 | Hall 6, Stall F37 | Düsseldorf, Germany
Precision-engineered peripheral IV catheter available in Pen-type, Winged, and Injection Port models with ISO color-coded hubs for rapid gauge recognition in high-turnover clinical wards.
Hospital-grade sterile disposable intravenous cannula featuring ultra-thin wall stainless steel needle for smooth venipuncture and optimal flow dynamics in emergency care.
Specialized scalp vein set / butterfly cannula tailored for veterinary intravenous infusion, small animal therapy, and delicate vascular access with flexible wing stabilization.
Heavy-duty 18G winged IV catheter with dedicated needleless injection port allowing needle-free secondary medication bolus administration without compromising system closed loop.
Small-gauge veterinary intravenous catheters designed specifically for companion animals, exotic pets, and pediatric veterinary medicine requiring precise vessel cannulation.
High-volume wholesale supply of sterile IV cannulas featuring an ergonomic clear flashback chamber equipped with a hydrophobic blood-stop filter to ensure instant blood visualization.
Advanced safety veterinary catheter featuring an automatic needle-shielding mechanism designed to eliminate needle-stick injuries among veterinary surgeons and clinical staff.
Comprehensive veterinary intravenous safety catheter series engineered for both livestock (equine, bovine) and small animal care across Italian veterinary hospital networks.
The Italian healthcare sector represents one of Europe's most sophisticated and rigorously regulated markets for single-use medical devices and hypodermic syringes. Driven by the public health network—the Servizio Sanitario Nazionale (SSN)—and regional procurement agencies (Aziende Sanitarie Locali - ASL), Italian importers, hospital groups, and medical distributors demand an uncompromised balance of technological precision, stringent compliance under EU MDR 2017/745, and robust supply chain resilience. As a premier China-based manufacturer and global exporter of hypodermic syringes, IV access systems, and safety consumables, our production infrastructure is specifically optimized to meet and exceed Italian market standards.
In recent years, the Italian medical device landscape has undergone a structural transformation. Procurement centralizers such as Consip S.p.A. and regional purchasing portals (such as ARCA in Lombardy, Intercent-ER in Emilia-Romagna, and SoReSa in Campania) have placed heightened emphasis on Information Gain, total cost of ownership, risk mitigation regarding sharp injuries, and material non-toxicity (phthalate-free and DEHP-free polymers). By establishing direct manufacturing partnerships with top-tier Chinese facilities, Italian healthcare buyers secure direct access to cleanroom automated production, ISO 13485:2016 quality management systems, and complete technical dossiers certified for immediate registration in the Italian Ministry of Health's Repertorio Dispositivi Medici (RDM) database.
Our manufacturing operations operate under strict adherence to ISO 13485:2016 standards and ISO 7886-1 requirements for hypodermic syringes. Full technical documentation, including biocompatibility data (ISO 10993), EO sterilization validation (ISO 11135), and clinical evaluation reports, is readily available for Italian regulatory audit.
The transition from the legacy Medical Device Directive (MDD 93/42/EEC) to the stringent European Medical Device Regulation (EU MDR 2017/745) has fundamentally altered the supply chain dynamics for hypodermic syringes and disposable medical devices imported into Italy. MDR mandates comprehensive Post-Market Surveillance (PMS), Periodic Safety Update Reports (PSUR), Unique Device Identification (UDI tracking), and rigorous clinical evaluation for Class I, Ia, and IIa medical devices.
Chinese manufacturers leading the export trade to Italy have invested heavily in upgrading technical dossiers to align with MDR Annex II and III guidelines. Every consignment of hypodermic syringes and IV catheters exported to Italian ports (such as Genoa, Trieste, and Venice) is backed by an active CE Certificate issued by recognized EU Notified Bodies, EC Declaration of Conformity, and fully compliant labeling bearing UDI carrier barcoding (GS1 matrix) to ensure seamless traceability across Italian regional hospital stocks.
Public health spending in Italy is structured around regional authorities, where Consip executes framework contracts on behalf of the Ministry of Economy and Finance. Italian tenders evaluate hypodermic syringes not merely on unit price, but on multi-criteria technical scoring parameters, including:
Under Italian Legislative Decree n. 19/2014, implementing EU Directive 2010/32/EU, Italian healthcare facilities are legally required to implement safety-engineered medical devices to eliminate needle-stick injuries among healthcare workers. In response, Chinese export leaders have pioneered integrated safety hypodermic syringes and safety IV cannulas equipped with passive or active needle-shielding clips. These safety mechanisms automatically lock over the sharp needle tip upon withdrawal, locking permanently without requiring secondary manual activation by the nurse or physician.
Italy’s Piano Nazionale di Ripresa e Resilienza (PNRR - Mission 6) is injecting billions of euros into modernizing regional hospital equipment, digitalizing healthcare logistics, and enforcing green public procurement (Criteri Ambientali Minimi - CAM). Consequently, Italian buyers prioritize hypodermic syringes and IV tubing formulated from 100% virgin USP Class VI medical polypropylene (PP) that are entirely Phthalate-Free, DEHP-Free, and Latex-Free, preventing toxic chemical leaching during blood contact or fluid infusion and facilitating eco-friendly medical waste incineration.
| Technical Parameter | Standard Market Specification | China Top Exporter Benchmark (Our Facility) | Benefit to Italian Buyer / ASL Tender |
|---|---|---|---|
| MDR Compliance Status | MDD Legacy / Transitional Certificate | Full EU MDR 2017/745 Certified Technical Dossier | Zero import blockage; future-proofed for Italian customs |
| Needle Penetration Force | 0.45 N – 0.60 N | < 0.30 N (Ultra-sharp 3-bevel back-cut) | Reduced patient pain; compliance with Italian clinical standards |
| Plunger Barrel Friction | Variable glide resistance | Controlled micro-siliconization (< 0.15 N break-away) | Smooth, precise control during slow bolus injection |
| Chemical Safety | Standard PVC / Polypropylene mix | 100% USP Class VI Medical PP, DEHP/Phthalate-Free | Meets Italian CAM eco-procurement & pediatric safety criteria |
| CND & RDM Registration | Buyer handles registration manually | Pre-registered / Turnkey RDM Dossier support | Fast-track distribution listing in Italian Ministry of Health |
Medical consumable requirements vary significantly across Italy's diverse clinical environments—from major research hospitals in Milan and Rome to regional veterinary clusters in the agricultural heartlands.
In high-density medical hubs such as the Policlinico San Matteo (Pavia), Ospedale Maggiore Policlinico (Milan), and Policlinico Gemelli (Rome), hypodermic syringes and intravenous cannulas are deployed in intensive care units (ICU), emergency departments (DEA), and surgical suites. These clinical scenarios demand high-burst pressure resistance (up to 4.5 bar / 65 psi for Luer Lock syringes used with automated syringe pumps) and absolute sterility. Our Luer Lock syringes ensure zero risk of accidental disconnection during continuous infusion of vasoactive agents or anesthetics.
Italy’s expanding private healthcare sector—including clinic chains and outpatient diagnostic centers—requires versatile 2-part and 3-part disposable syringes ranging from 1 ml to 50 ml. These syringes are extensively utilized for routine phlebotomy, subcutaneous insulin administration, intramuscular vaccine delivery, and diagnostic contrast media injection. High transparency barrels with bold, laser-calibrated graduations allow rapid volumetric verification by outpatient nurses.
Pediatric wards and oncology day-hospitals across Italy demand micro-dose accuracy. Our 1 ml Fine-Ject zero dead-space insulin and tuberculin hypodermic syringes are fitted with integrated fine needles (26G to 30G). By eliminating dead space at the nozzle junction, precious oncology therapeutics and low-volume neonatal medications are delivered with zero residual volume waste, maximizing clinical efficacy and reducing pharmacy expenses.
Beyond human medicine, Italy boasts a world-class agricultural and animal health industry. Regions like Emilia-Romagna (Piacenza, Parma, Reggio Emilia) and Piedmont represent major livestock and equine breeding zones, alongside a rapidly growing domestic pet market. Our specialized range of veterinary hypodermic syringes, heavy-duty 14G-18G veterinary IV cannulas, and butterfly infusion catheters are engineered with reinforced walls and high-tensile stainless steel needles designed to penetrate tough animal hides while remaining stable during animal movement.
Our state-of-the-art production complex utilizes fully automated injection molding, high-speed assembly robotics, and continuous optical inspection systems housed entirely within Class 100,000 cleanrooms. Human contact is minimized, ensuring bioburden levels remain well below ISO 11737 baseline limits prior to sterilization.
Needle cannulae are crafted from medical-grade AISI 304 stainless steel, featuring ultra-sharp 3-facet back-cut bevel geometry. Automated micro-spraying of medical-grade silicone fluid (Dow Corning) guarantees uniform distribution, reducing tissue drag and insertion force below 0.3 N.
Sterilization is executed in automated Ethylene Oxide (EO) chambers validated in strict accordance with EN ISO 11135:2014. Post-sterilization aeration cycles reduce residual ethylene oxide and ethylene chlorohydrin gases to levels far below 1 µg/g, fully complying with European pharmacopeia safety standards.
We empower Italian medical brands and regional importers through complete OEM turnkey services. This includes custom inner unit blister design, multilingual IFU printing (Italian, English, German, French), custom carton barcoding (GS1-128), and regulatory assistance for fast-track local registration.
Our hypodermic syringes and IV access devices are fully categorized under the Italian Classificazione Nazionale Dispositivi Medici (CND) coding system (e.g., Category A for injection devices, Category C for intravascular catheters). We supply Italian distributors with complete technical documentation, CE certificates, and test reports required to submit product registration directly into the Italian Ministry of Health's Repertorio Dispositivi Medici (RDM) database, enabling immediate participation in ASL and Consip public tenders.
Every export consignment is shipped with a comprehensive quality clearance file, including: EU MDR CE Certificate of Conformity, ISO 13485:2016 Quality Management Certificate, Certificate of Free Sale (CFS), Batch Certificate of Analysis (CoA), Ethylene Oxide (EO) Sterilization Validation & Residual Gas Report, Biocompatibility Test Summaries (ISO 10993), and Packing List / Commercial Invoice formatted for smooth clearance through Italian customs at Genoa, Trieste, or Milan Malpensa cargo hubs.
Yes. We provide end-to-end OEM and private-label manufacturing for Italian healthcare brands. Our design team prepares artwork for primary unit blister pouches, inner boxes, and master shipping cartons strictly in compliance with EU labeling requirements. All Instructions for Use (IFU), safety warnings, storage temperatures, and UDI symbol legends are printed in professional Italian (
Absolute safety is our primary engineering metric. All hypodermic syringe barrels and plungers are injection-molded from 100% virgin medical-grade Polypropylene (PP). Gaskets are manufactured from synthetic latex-free elastomer compound. The complete assembly is verified to be entirely DEHP-Free, Phthalate-Free, Latex-Free, non-toxic, and certified non-pyrogenic (< 0.25 EU/ml endotoxin limit as per European Pharmacopoeia standards).
For standard catalogue neutral packaging items, minimum order quantities start at 100,000 units per SKU (or 1 mixed 20ft container). For custom OEM private label artwork, typical MOQs are 200,000 units per gauge SKU. Standard production lead time is 25 to 30 days from artwork approval, with sea freight transport to Italian ports (Genoa / Trieste) taking approximately 28 to 35 days depending on shipping line routing.
Our safety hypodermic syringes feature integrated safety shield mechanisms. Upon completing the injection, the clinician triggers the protective shield, which permanently locks over the contaminated needle tip with an audible "click". This prevents accidental needle-stick injuries during disposal, fulfilling the mandatory legal requirements outlined under Italian Legislative Decree n. 19/2014 and EU Directive 2010/32/EU for hospital procurement.
We offer flexible international commercial terms tailored to Italian buyers, including FOB (Shanghai / Ningbo / Qingdao), CIF (Genoa / Trieste / Venice), and DDP (Delivered Duty Paid directly to your regional warehouse in Italy). Payment terms generally operate via Irrevocable Letter of Credit (L/C at sight) or Telegraphic Transfer (T/T) with deposit terms structured for established distribution partners.